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Introduction
Ovarian hyperstimulation syndrome (OHSS) is con-
sidered to be an iatrogenic complication of ovulation
induction therapy for in vitro fertilization in approxi-
mately 10% of cases [1]. In its most severe form, OHSS
involves massive ovarian enlargement, formation of
multiple ovarian cysts, fluid shifts resulting in extravas-
cular fluid accumulation and intravascular volume
depletion, renal failure, hypovolemic shock, and, in
some cases, death. This severe form is rare, with a
reported incidence of 0.5–5% among patients undergo-
ing ovulation induction therapy [2].
Although OHSS most commonly occurs as a result
of exogenous administration of gonadotropins, spon-
taneous OHSS has been reported in rare instances
during pregnancy, most often in situations where there
is supraphysiologic production of chorionic gonadotro-
pin, such as multiple gestations or molar pregnancies.
Chorionic gonadotropin production typically peaks
around the 9th week of gestation and decreases there-
after. In parallel with this course, spontaneous OHSS
is usually most severe during the first trimester of 
pregnancy [2].
The pathologic features of OHSS, whether sponta-
neous or iatrogenic, include the presence of multiple
serous and hemorrhagic follicular cysts lined by luteinized
cells, a condition called hyperreactio luteinalis [1,2].
We describe a case of spontaneous OHSS in a
woman who became pregnant naturally and who had
no underlying disease.
Case Report
A 19-year-old primigravid patient was admitted to our
clinic with the complaints of abdominal distension,
pain and nausea; these complaints had been present
for 4 days. She had regular menses before her preg-
nancy and had a gestation of 9 weeks 4 days based 
on her last menstruation. She had no history of ovula-
tion induction or any medication within the last 6
months. She also had no history of acne or hirsutism.
Family history was negative for both polycystic ovary
syndrome and diabetes mellitus.
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On admission, she had a blood pressure of 
90/60 mmHg, while her pulse rate was 104 beats/
minute. Bilateral pelvic masses extending to the upper
abdomen were found on pelvic examination. The
masses felt cystic, with lobulated surfaces, and they
were freely mobile. She had a hemoglobin level of
12.3 g/dL and hematocrit was 35.3%. Both estradiol
and β-hCG levels were elevated (6,200 pg/mL and
143,393 mIU/mL, respectively). The CA-125 level was
440 IU/mL. Other laboratory findings, including thy-
roid function tests and androgen levels, were within
normal limits, except for serum albumin level, which
was slightly lower than normal (3.2 g/dL). Ultraso-
nography showed a 10-week old live single intrauterine
fetus and bilateral multilocular cystic masses meas-
uring 15 cm in size on the left and 10 cm on the 
right (Figure). A mild degree of ascites was also noted.
Chest X-ray and Doppler ultrasonographic studies
were normal.
Since the patient had a high level of CA-125, bilat-
eral multicystic ovaries and ascites, we decided to per-
form paracentesis to rule out malignancy. Pathologic
examination showed benign cytology.
Due to the patient’s history and laboratory find-
ings, the diagnosis of spontaneous OHSS was consid-
ered. We decided to manage the patient expectantly
since her vital signs and general condition were stable.
Ultrasonography was performed, and complete blood
count, serum electrolytes and albumin concentrations
were measured every other day.
During the following 6 weeks, the patient required no
intervention and laboratory findings remained within
normal ranges; the ascites resolved and the bilateral
ovarian masses decreased in size to 7 cm on the left
and 5.5 cm on the right. At 20 weeks of gestation, the
cysts could not be seen. The patient by then had been
taken into our normal prenatal follow-up procedure
and delivered a healthy female baby at 39 weeks of
gestation.
Discussion
The pathophysiologic mechanism underlying OHSS
has yet to be elucidated. The severity of the syndrome
is related to the degree of ovarian follicular response.
Estrogens, produced by the developing follicles, may
reach high levels and serve as markers of the degree of
ovarian hyperstimulation [1,2].
According to some authors, OHSS will not develop
until final follicular maturation and luteinization occurs
in response to hCG or luteinizing hormone; this process
results in the ovarian secretion of vasoactive substances
that cause increased capillary permeability, triggering
this syndrome. Possible mediators of increased vascular
permeability include vascular endothelial growth fac-
tor, components of the renin–angiotensin system and
cytokines [2,3]. Kemmann et al have postulated that
increased levels of estradiol and androgen, beside the
absence of synchrony between follicular gathering and
ripening, might be the predisposing factors in patients
undergoing ovulation induction treatments and also
in nonstimulated cases [4].
On the other hand, some authors have suggested the
presence of an underlying polycystic ovary syndrome in
these cases, with the typical hormonal and ovulatory
alterations associated with this dysfunction [5,6].
In our case, there was no history of polycystic ovary
syndrome. Although estradiol was significantly elevated,
androgen levels were within the normal range. β-hCG
was significantly elevated in our case, but some authors
reported low levels of β-hCG in such cases [3]. Con-
sequently, β-hCG may not be a trigger in every case.
OHSS may also be associated with hypothyroid-
ism, and there are some reports in the literature that
support this relationship [7,8]. Elevated thyroid stimu-
lating hormone levels may mediate ovarian hyperstim-
ulation via nuclear thyroid receptors in the granulosa
cells. Thyroid function tests were within normal limits
in the present case.
OHSS has also been described in twin and molar
pregnancies [9]. Our patient had a singleton preg-
nancy and, despite the high level of β-hCG, we did not
suspect molar pregnancy.
Paracentesis showed benign cytology, and Doppler
ultrasonography was normal in our case, thus exclud-
ing the diagnosis of ovarian malignancy. Although
serum CA-125 was high in this patient, serum CA-125
measurements are not useful for differential diagnosis
since they are usually elevated, as expected in patients
with gross ovarian enlargement.
Pregnancy luteoma and hyperreactio luteinalis are
two rare entities that should be included in the differen-
tial diagnosis of spontaneous OHSS. These conditions
Figure. Enlarged ovaries in the form of cystic masses are seen
on the left and the fetus is seen on the right.
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are associated with large ovarian masses and were orig-
inally thought to reflect different ends of a pathologic
spectrum resulting from hyperresponsiveness to hCG. It
now appears that they are distinct clinical entities.
Pregnancy luteoma, which is a nodular hyperplasia
of luteinized gonadal stromal or thecal cells, generally
emerges during the last trimester of pregnancy and
regresses spontaneously after delivery [10,11]. Most of
the patients with pregnancy luteoma in their 30s and
40s are multiparous. Virilization is common in these
patients and in their female infants. This condition is
frequently unilateral and nonpalpable. Since it is gen-
erally asymptomatic, the majority of cases are diag-
nosed unexpectedly by ultrasonography or during the
course of cesarean section or tubal ligation.
On the other hand, hyperreactio luteinalis usually
presents with bilateral ovarian enlargement, which is
caused by multiple theca lutein cysts. Some authors
suggest that spontaneous OHSS and hyperreactio
luteinalis are entities in a continuum [12]. Hyperreactio
luteinalis frequently occurs in patients with gestational
trophoblastic disease, multiple pregnancies and fetal
hydrops. It is rare in singleton pregnancies. Although
this condition is generally asymptomatic, it may pres-
ent with acute abdominal symptoms when hemorrhage
into the cysts, rupture or torsion occur. Virilization is
rare in this condition and the cysts resolve following
delivery. The majority of cases occur in the third trimester
or immediately postpartum. Hyperreactio luteinalis
presents with a more indolent course and is usually 
seen later than spontaneous OHSS, which presents
more acutely and earlier in pregnancy [10,11,13]. Finally,
the cardinal feature of OHSS, increased vascular per-
meability as manifested by edema and ascites, is not a
usual finding in pregnancy luteoma and hyperreactio
luteinalis. Based on these, and given the clinical fea-
tures of the case, the diagnosis of spontaneous OHSS
was established for our patient.
Time of onset and duration of the condition in this
patient obviously differ from that of iatrogenic OHSS,
which is usually seen earlier in the course of pregnancy.
Spontaneous forms of OHSS generally develop between
8 and 14 weeks of amenorrhea, differing from iatrogenic
OHSS, which usually starts between 3 and 5 weeks 
of amenorrhea. The recent identification of mutations 
in the follicle stimulating hormone (FSH) receptor
gene, which display an increased sensitivity to hCG and
are responsible for the development of spontaneous
OHSS, helps us to understand this problem [14]. In
iatrogenic OHSS, the follicular recruitment and
enlargement occur during the administration of exoge-
nous FSH. In the spontaneous form however, the fol-
licular recruitment and growth occur later through the
promiscuous stimulation, by pregnancy-derived hCG,
of a mutated FSH receptor that is abnormally sensitive
to hCG or a wildtype FSH receptor in the presence of
abnormally high levels of hCG. Thus, the symptoma-
tology of spontaneous cases of OHSS usually develops
at 8 weeks’ amenorrhea and culminates at the end of
the first trimester of pregnancy.
Since the syndrome is usually self-limiting, many
authors recommend the continuation of pregnancy. In
almost all cases, the disease regresses spontaneously
with time or delivery. On the other hand, deaths due to
hypovolemia, hemorrhage and thromboembolic phe-
nomena have been reported [15]. Hospitalization is
required in most cases. Monitoring of hemodynamic
status, intravenous crystalloid and albumin infusion
and prophylaxis of thrombosis are the main principles
of management [6,14]. Termination of pregnancy can
be considered when conservative management fails,
but surgery should be reserved for cases of ovarian
rupture, torsion and intraperitoneal hemorrhage.
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